Pulmonary Hypertension | Norton Healthcare

Indication: Pulmonary Hypertension

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects with Pulmonary Hypertension (PH) in Heart Failure with Preserved Ejection Fraction (HFpEF)

Drug Study

Principal Investigator: John McConnell, M.D.
Norton Pulmonary Specialists

Sponsor: UNITED THERAPEUTICS CORPORATION

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.